ThZeal - The Zeal

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Atomico Advisors IV, Ltd.

(Last)

(First)

(Middle)

ONE CAPITAL PLACE

(Street)

GRAND CAYMAN

KY1-1103

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/21/2025

3. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series A-2 Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	4,830,917	⁽¹⁾	I	See footnote⁽²⁾⁽³⁾
Series B Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	2,245,545	⁽¹⁾	I	See footnote⁽²⁾⁽⁴⁾
Series C Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	1,175,333	⁽¹⁾	I	See footnote⁽²⁾⁽⁵⁾
Series C-1 Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	602,298	⁽¹⁾	I	See footnote⁽²⁾⁽⁶⁾
Series D Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	510,073	⁽¹⁾	I	See footnote⁽²⁾⁽⁷⁾

1. Name and Address of Reporting Person^*

Atomico Advisors IV, Ltd.

(Last)

(First)

(Middle)

ONE CAPITAL PLACE

(Street)

GRAND CAYMAN

KY1-1103

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Atomico IV, L.P.

(Last)

(First)

(Middle)

ONE CAPITAL PLACE

(Street)

GRAND CAYMAN

KY1-1103

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Atomico IV (Guernsey), L.P.

(Last)

(First)

(Middle)

PO BOX 286

FLOOR 2 TRAFALGAR COURT, LES BANQUES

(Street)

ST PETER PORT

GY1 4LY

(City)

(State)

(Zip)

Relationship of Reporting Person(s) to Issuer

Director	X	10% Owner
Officer (give title below)		Other (specify below)

Explanation of Responses:

1. Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stockof the Issuer, except for the Series E Preferred Stock, will automatically convert and be reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of newly classified Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation.

2. Atomico Advisors IV, Ltd. is the general partner of Atomico IV L.P. ("Atomico IV") and Atomico IV (Guernsey), L.P. ("Atomico IV (Guernsey)"). As a result, Atomico Advisors IV, Ltd. may be deemed to have beneficial ownership of the shares held by each of Atomico IV and Atomico IV (Guernsey).

3. Consists of (i) 3,941,353 shares held by Atomico IV and (ii) 889,564 shares held by Atomico IV (Guernsey).

4. Consists of (i) 1,832,051 shares held by Atomico IV and (ii) 413,494 shares held by Atomico IV (Guernsey).

5. Consists of (i) 958,908 shares held by Atomico IV and (ii) 216,425 shares held by Atomico IV (Guernsey).

6. Consists of (i) 491,398 shares held by Atomico IV and (ii) 110,900 shares held by Atomico IV (Guernsey).

7. Consists of (i) 416,148 shares held by Atomico IV and (ii) 93,925 shares held by Atomico IV (Guernsey).

	Atomico Advisors IV, Ltd., By: /s/ Claris Ruwende	05/21/2025
	Atomico IV L.P, By: /s/ Claris Ruwende	05/21/2025
	Atomico IV (Guernsey), L.P., By: /s/ Claris Ruwende	05/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.